{
    "code": "01049448",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049448",
    "time": "2019-09-27 03:18:14",
    "許可證字號": "衛署藥製字第049448號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/05\/20",
    "發證日期": "97\/05\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104944801",
    "中文品名": "骨精敏加強型口服溶液用粉劑",
    "英文品名": "BonJine Extra Powder for Oral Solution",
    "適應症": "緩解退化性關節炎之疼痛。",
    "劑型": "145溶液用粉劑",
    "包裝": "2~250包裝 每包4公克鋁箔袋盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "主成分略述": "CRYSTALLINE GLUCOSAMINE SULFATE",
    "主製造廠": {
        "申請商名稱": "6201091130  瑞安大藥廠股份有限公司",
        "申請商地址": "台北市松山區光復南路1號12樓之2",
        "主製造廠": "",
        "製造廠名稱": "1315004300  瑞安大藥廠股份有限公司觀音廠"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9600013340",
            "成分名稱": "CRYSTALLINE GLUCOSAMINE SULFATE",
            "含量描述": "(Eq. to Glucosamine Sulfate 1500mg)",
            "含量": "1884.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Bonjine_INS_01_201509-104-11-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049448&Seq=004&Type=9"
        },
        {
            "title": "Bonjine_049448_PC.PL-104-12-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049448&Seq=009&Type=8"
        }
    ]
}